<DOC>
	<DOCNO>NCT01084122</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy intravenous iron sucrose patient hip fracture surgical intervention prevent perioperative anemia .</brief_summary>
	<brief_title>Efficacy Safety Intravenous Iron Sucrose Patients With Hip Fracture Prevent Perioperative Anemia</brief_title>
	<detailed_description>The main objective study evaluate safety efficacy intravenous iron sucrose patient hip fracture surgical intervention prevent perioperative anemia . It also determine whether intravenous iron sucrose administration improve outcome Haemoglobin value , transfusional need , postoperative complication , length hospital stay cost-effectiveness .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Ferric oxide , saccharated</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>Age &gt; = 65 year old With Hip fracture peritrochanteric fracture . Who need surgical intervention . And sign inform consent form . Tumor pathological fracture . Two long bone fracture . Seric Ferritin level &gt; 300 ng/ml . Hypersensitivity Iron sucrose component formulation . Patients allogeneic transfusion rejection . Patients previous blood transfusion request ( Hb &lt; 8g/dl ) . Patients treat hematopoietic growth factor . Patients Anticoagulant treatment , due thromboembolic high risk disease . Asthma treatment . Cirrhosis , Acute Hepatitis , increase Aminotransferases ( &gt; 3 time upper limit normal ) . Advanced Dementia ( GDS &gt; 5 ) Global Deterioration Scale .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Intravenous iron sucrose</keyword>
	<keyword>Anemia</keyword>
	<keyword>Transfusion</keyword>
</DOC>